A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...

The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease.

A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...